vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and MANHATTAN ASSOCIATES INC (MANH). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $270.4M, roughly 1.8× MANHATTAN ASSOCIATES INC). MANHATTAN ASSOCIATES INC runs the higher net margin — 19.2% vs -10.1%, a 29.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 5.7%). MANHATTAN ASSOCIATES INC produced more free cash flow last quarter ($142.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 3.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Computer Associates International, Inc., later CA, Inc., and CA Technologies, Inc., was an American multinational enterprise software developer and publisher that existed from 1976 to 2018. CA grew to rank as one of the largest independent software corporations in the world, and at one point was the second largest. The company created systems software that ran in IBM mainframe, distributed computing, virtual machine, and cloud computing environments.

CLOV vs MANH — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.8× larger
CLOV
$487.7M
$270.4M
MANH
Growing faster (revenue YoY)
CLOV
CLOV
+39.0% gap
CLOV
44.7%
5.7%
MANH
Higher net margin
MANH
MANH
29.3% more per $
MANH
19.2%
-10.1%
CLOV
More free cash flow
MANH
MANH
$211.4M more FCF
MANH
$142.4M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
3.1%
MANH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
MANH
MANH
Revenue
$487.7M
$270.4M
Net Profit
$-49.3M
$52.0M
Gross Margin
55.0%
Operating Margin
-10.1%
24.8%
Net Margin
-10.1%
19.2%
Revenue YoY
44.7%
5.7%
Net Profit YoY
-123.2%
8.2%
EPS (diluted)
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
MANH
MANH
Q4 25
$487.7M
$270.4M
Q3 25
$496.6M
$275.8M
Q2 25
$477.6M
$272.4M
Q1 25
$462.3M
$262.8M
Q4 24
$337.0M
$255.8M
Q3 24
$331.0M
$266.7M
Q2 24
$356.3M
$265.3M
Q1 24
$346.9M
$254.6M
Net Profit
CLOV
CLOV
MANH
MANH
Q4 25
$-49.3M
$52.0M
Q3 25
$-24.4M
$58.6M
Q2 25
$-10.6M
$56.8M
Q1 25
$-1.3M
$52.6M
Q4 24
$-22.1M
$48.0M
Q3 24
$-9.2M
$63.8M
Q2 24
$7.4M
$52.8M
Q1 24
$-19.2M
$53.8M
Gross Margin
CLOV
CLOV
MANH
MANH
Q4 25
55.0%
Q3 25
56.6%
Q2 25
57.3%
Q1 25
56.4%
Q4 24
55.8%
Q3 24
24.5%
55.5%
Q2 24
30.3%
54.8%
Q1 24
23.6%
53.1%
Operating Margin
CLOV
CLOV
MANH
MANH
Q4 25
-10.1%
24.8%
Q3 25
-4.9%
27.5%
Q2 25
-2.2%
27.1%
Q1 25
-0.3%
24.0%
Q4 24
-6.4%
23.7%
Q3 24
-2.7%
28.2%
Q2 24
2.0%
25.7%
Q1 24
-6.5%
22.6%
Net Margin
CLOV
CLOV
MANH
MANH
Q4 25
-10.1%
19.2%
Q3 25
-4.9%
21.3%
Q2 25
-2.2%
20.8%
Q1 25
-0.3%
20.0%
Q4 24
-6.6%
18.8%
Q3 24
-2.8%
23.9%
Q2 24
2.1%
19.9%
Q1 24
-5.5%
21.1%
EPS (diluted)
CLOV
CLOV
MANH
MANH
Q4 25
$0.86
Q3 25
$0.96
Q2 25
$0.93
Q1 25
$0.85
Q4 24
$0.77
Q3 24
$1.03
Q2 24
$0.85
Q1 24
$0.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
MANH
MANH
Cash + ST InvestmentsLiquidity on hand
$78.3M
$328.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$314.8M
Total Assets
$541.0M
$839.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
MANH
MANH
Q4 25
$78.3M
$328.7M
Q3 25
$263.6M
Q2 25
$230.6M
Q1 25
$205.9M
Q4 24
$194.5M
$266.2M
Q3 24
$288.0M
$215.0M
Q2 24
$254.8M
$202.7M
Q1 24
$208.3M
$207.5M
Stockholders' Equity
CLOV
CLOV
MANH
MANH
Q4 25
$308.7M
$314.8M
Q3 25
$340.9M
$309.2M
Q2 25
$344.2M
$278.8M
Q1 25
$336.1M
$245.1M
Q4 24
$341.1M
$299.1M
Q3 24
$342.2M
$278.0M
Q2 24
$324.9M
$240.6M
Q1 24
$292.5M
$239.6M
Total Assets
CLOV
CLOV
MANH
MANH
Q4 25
$541.0M
$839.4M
Q3 25
$559.7M
$768.8M
Q2 25
$575.0M
$744.7M
Q1 25
$583.7M
$708.2M
Q4 24
$580.7M
$757.6M
Q3 24
$653.0M
$698.1M
Q2 24
$674.2M
$665.3M
Q1 24
$671.8M
$674.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
MANH
MANH
Operating Cash FlowLast quarter
$-66.9M
$147.1M
Free Cash FlowOCF − Capex
$-69.0M
$142.4M
FCF MarginFCF / Revenue
-14.1%
52.7%
Capex IntensityCapex / Revenue
0.4%
1.7%
Cash ConversionOCF / Net Profit
2.83×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$374.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
MANH
MANH
Q4 25
$-66.9M
$147.1M
Q3 25
$12.1M
$93.1M
Q2 25
$5.4M
$74.0M
Q1 25
$-16.3M
$75.3M
Q4 24
$34.8M
$104.7M
Q3 24
$50.0M
$62.3M
Q2 24
$44.8M
$73.3M
Q1 24
$25.9M
$54.7M
Free Cash Flow
CLOV
CLOV
MANH
MANH
Q4 25
$-69.0M
$142.4M
Q3 25
$11.4M
$87.2M
Q2 25
$4.8M
$70.1M
Q1 25
$-16.5M
$74.4M
Q4 24
$33.3M
$101.6M
Q3 24
$49.6M
$61.3M
Q2 24
$44.4M
$71.0M
Q1 24
$25.5M
$52.4M
FCF Margin
CLOV
CLOV
MANH
MANH
Q4 25
-14.1%
52.7%
Q3 25
2.3%
31.6%
Q2 25
1.0%
25.7%
Q1 25
-3.6%
28.3%
Q4 24
9.9%
39.7%
Q3 24
15.0%
23.0%
Q2 24
12.5%
26.8%
Q1 24
7.3%
20.6%
Capex Intensity
CLOV
CLOV
MANH
MANH
Q4 25
0.4%
1.7%
Q3 25
0.1%
2.1%
Q2 25
0.1%
1.5%
Q1 25
0.0%
0.3%
Q4 24
0.5%
1.2%
Q3 24
0.1%
0.4%
Q2 24
0.1%
0.8%
Q1 24
0.1%
0.9%
Cash Conversion
CLOV
CLOV
MANH
MANH
Q4 25
2.83×
Q3 25
1.59×
Q2 25
1.30×
Q1 25
1.43×
Q4 24
2.18×
Q3 24
0.98×
Q2 24
6.04×
1.39×
Q1 24
1.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

MANH
MANH

Service Other$120.0M44%
Cloud Subscriptions$108.6M40%
Maintenance$32.3M12%
Hardware$6.9M3%
License And Maintenance$2.6M1%

Related Comparisons